Pharmacovigilance and Drug Safety in Oncology

Pharmacovigilance and Drug Safety in Oncology involve the monitoring, assessment, and prevention of adverse effects associated with cancer treatments, including chemotherapy, immunotherapy, targeted therapy, and other oncological drugs. Pharmacovigilance is the science of detecting, evaluating, understanding, and preventing side effects or any other drug-related problems. In oncology, this is particularly important due to the potential severity of side effects and the complex nature of cancer treatments. Ensuring drug safety involves ongoing surveillance, clinical trials, reporting of adverse events, and post-market monitoring to improve treatment outcomes and minimize harm to patients. This field aims to enhance the effectiveness and safety of cancer therapies, providing better care for patients while reducing risks associated with cancer medications.

    Related Conference of Pharmacovigilance and Drug Safety in Oncology

    November 25-26, 2024

    7th International Conference on Anti-Cancer Drugs & Therapies

    Vancouver, Canada
    November 28-29, 2024

    14th World Congress on Breast Cancer

    Paris, France
    December 10-11, 2024

    8th Global Meeting on Oncology and Radiology

    Dubai, UAE
    December 11-12, 2024

    34th Experts Meet On Cancer Research & Therapy

    Paris, France
    December 12-13, 2024

    44th Euro Congress on Cancer Science & Therapy

    Rome, Italy
    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands

    Pharmacovigilance and Drug Safety in Oncology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in